LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 23.39 | 770.25 | 1122 | 2244 | 0.4999 | 0.2761 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 25.62 | 770.25 | 1374 | 2514 | 0.5464 | 0.4036 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 25.62 | 770.25 | 1141 | 2514 | 0.4537 | 0.2588 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 27.84 | 770.25 | 1408 | 2833 | 0.4969 | 0.3785 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 27.84 | 770.25 | 1181 | 2833 | 0.4167 | 0.2554 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 30.06 | 770.25 | 1440 | 3106 | 0.4636 | 0.3648 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 30.06 | 770.25 | 1184 | 3106 | 0.3812 | 0.2383 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 32.28 | 770.25 | 1463 | 3392 | 0.4312 | 0.3497 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 32.28 | 770.25 | 1195 | 3392 | 0.3522 | 0.2279 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 34.50 | 770.25 | 1483 | 3712 | 0.3995 | 0.3348 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 34.50 | 770.25 | 1233 | 3712 | 0.3322 | 0.2304 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 36.73 | 770.25 | 1518 | 4086 | 0.3715 | 0.3255 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 36.73 | 770.25 | 1253 | 4086 | 0.3067 | 0.2240 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 38.95 | 770.25 | 1539 | 4543 | 0.3387 | 0.3104 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 38.95 | 770.25 | 1268 | 4543 | 0.2791 | 0.2149 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 41.17 | 770.25 | 1554 | 5010 | 0.3101 | 0.2967 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 41.17 | 770.25 | 1280 | 5010 | 0.2555 | 0.2068 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 43.39 | 770.25 | 1587 | 5404 | 0.2937 | 0.2933 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 43.39 | 770.25 | 1309 | 5404 | 0.2422 | 0.2076 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 45.61 | 770.25 | 1612 | 5813 | 0.2773 | 0.2882 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 45.61 | 770.25 | 1320 | 5813 | 0.2271 | 0.2029 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 47.83 | 770.25 | 1650 | 6223 | 0.2651 | 0.2875 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 47.83 | 770.25 | 1345 | 6223 | 0.2161 | 0.2031 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 50.05 | 770.25 | 1666 | 6629 | 0.2513 | 0.2820 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 50.05 | 770.25 | 1360 | 6629 | 0.2051 | 0.2009 | MN20160304_L02 | E18 |